SALT LAKE CITY, Jan 12, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its fiscal 2010 second quarter financial results at the close of market on Tuesday, February 2, 2010.
The Company will host a conference call on Tuesday, February 2, at 4:30 p.m. Eastern to review the financial results. Participating on the call will be: Peter D. Meldrum, President and Chief Executive Officer; Jim Evans, Chief Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and Mark C. Capone, Chief Operating Officer of Myriad Genetic Laboratories, Inc.
To participate on the call, callers may dial (800) 705-1680 or (416) 981-9090 approximately 10-15 minutes before the start of the call. All callers will be asked to reference reservation number 21455442.
The conference call also will be available to interested parties through a live audio Internet broadcast at www.myriad.com.
A replay of the call will be available beginning two hours after the end of the call until seven days following the call and may be accessed by dialing (800) 633-8625 or (402) 977-9141, and entering the reservation number 21455442.
Myriad Genetics, Inc. is a leading molecular diagnostic company focused on developing and marketing novel predictive medicine, personalized medicine and prognostic medicine products. Myriad's news and other information are available on the Company's Web site at www.myriad.com.
The Myriad Genetics, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6336
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Myriad Genetics, Inc.
CONTACT: Myriad Genetics, Inc. Suzanne Barton, Director, Investor Relations (801) 584-1138 firstname.lastname@example.org
(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.
News Provided by COMTEX